Novocure Non Current Liabilities Total from 2010 to 2025

NVCR Stock  USD 21.55  0.55  2.62%   
Novocure Non Current Liabilities Total yearly trend continues to be relatively stable with very little volatility. Non Current Liabilities Total is likely to grow to about 730 M this year. During the period from 2010 to 2025, Novocure Non Current Liabilities Total destribution of quarterly values had range of 728.4 M from its regression line and mean deviation of  259,544,983. View All Fundamentals
 
Non Current Liabilities Total  
First Reported
2014-12-31
Previous Quarter
681.2 M
Current Value
126.2 M
Quarterly Volatility
243.4 M
 
Yuan Drop
 
Covid
Check Novocure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novocure's main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.8 M, Interest Expense of 7.6 M or Selling General Administrative of 198.1 M, as well as many indicators such as Price To Sales Ratio of 3.41, Dividend Yield of 0.0 or PTB Ratio of 3.75. Novocure financial statements analysis is a perfect complement when working with Novocure Valuation or Volatility modules.
  
Check out the analysis of Novocure Correlation against competitors.
To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.

Latest Novocure's Non Current Liabilities Total Growth Pattern

Below is the plot of the Non Current Liabilities Total of Novocure over the last few years. It is Novocure's Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novocure's overall financial position and show how it may be relating to other accounts over time.
Non Current Liabilities Total10 Years Trend
Slightly volatile
   Non Current Liabilities Total   
       Timeline  

Novocure Non Current Liabilities Total Regression Statistics

Arithmetic Mean265,542,387
Geometric Mean54,035,822
Coefficient Of Variation108.26
Mean Deviation259,544,983
Median162,974,000
Standard Deviation287,475,453
Sample Variance82642.1T
Range728.4M
R-Value0.94
Mean Square Error10997.2T
R-Squared0.88
Slope56,507,973
Total Sum of Squares1239632T

Novocure Non Current Liabilities Total History

2025730 M
2024695.2 M
2023604.5 M
2022591.7 M
2021586.4 M
2020461.8 M
2019175.3 M

About Novocure Financial Statements

Novocure shareholders use historical fundamental indicators, such as Non Current Liabilities Total, to determine how well the company is positioned to perform in the future. Although Novocure investors may analyze each financial statement separately, they are all interrelated. The changes in Novocure's assets and liabilities, for example, are also reflected in the revenues and expenses on on Novocure's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Non Current Liabilities Total695.2 M730 M

Additional Tools for Novocure Stock Analysis

When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.